171 related articles for article (PubMed ID: 19176794)
1. The costs and benefits of automatic estimated glomerular filtration rate reporting.
den Hartog JR; Reese PP; Cizman B; Feldman HI
Clin J Am Soc Nephrol; 2009 Feb; 4(2):419-27. PubMed ID: 19176794
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.
Ishigami J; Padula WV; Grams ME; Chang AR; Jaar B; Gansevoort RT; Bridges JFP; Kovesdy CP; Uchida S; Coresh J; Matsushita K
Am J Kidney Dis; 2019 Jul; 74(1):23-35. PubMed ID: 30898360
[TBL] [Abstract][Full Text] [Related]
3. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
Ferguson TW; Tangri N; Tan Z; James MT; Lavallee BDA; Chartrand CD; McLeod LL; Dart AB; Rigatto C; Komenda PVJ
Kidney Int; 2017 Jul; 92(1):192-200. PubMed ID: 28433383
[TBL] [Abstract][Full Text] [Related]
4. Routine reporting of estimated glomerular filtration rate (eGFR) in African laboratories and the need for its increased utilisation in clinical practice.
Adebisi SA
Niger Postgrad Med J; 2013 Mar; 20(1):57-62. PubMed ID: 23661212
[TBL] [Abstract][Full Text] [Related]
5. The relationship between serum creatinine and estimated glomerular filtration rate: implications for clinical practice.
Nelson AW; Mackinnon B; Traynor J; Geddes CC
Scott Med J; 2006 Nov; 51(4):5-9. PubMed ID: 17137139
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
[TBL] [Abstract][Full Text] [Related]
7. Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease.
Rule AD
Curr Opin Nephrol Hypertens; 2007 May; 16(3):242-9. PubMed ID: 17420668
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement.
Mathew TH;
Med J Aust; 2005 Aug; 183(3):138-41. PubMed ID: 16053416
[TBL] [Abstract][Full Text] [Related]
9. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.
Hopkins RB; Garg AX; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Parfrey PS; Barrett BJ; Goeree R
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1248-57. PubMed ID: 21617091
[TBL] [Abstract][Full Text] [Related]
11. Population based screening for chronic kidney disease: cost effectiveness study.
Manns B; Hemmelgarn B; Tonelli M; Au F; Chiasson TC; Dong J; Klarenbach S;
BMJ; 2010 Nov; 341():c5869. PubMed ID: 21059726
[TBL] [Abstract][Full Text] [Related]
12. Comparison of creatinine and cystatin formulae with
Cholongitas E; Ioannidou M; Goulis I; Chalevas P; Ntogramatzi F; Athanasiadou Z; Notopoulos A; Alevroudis M; Sinakos E; Akriviadis E
J Gastroenterol Hepatol; 2017 Jan; 32(1):191-198. PubMed ID: 27177318
[TBL] [Abstract][Full Text] [Related]
13. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
Mitchell T; Hadlow N; Chakera A
Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
[TBL] [Abstract][Full Text] [Related]
14. Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association.
Pattaro C; Riegler P; Stifter G; Modenese M; Minelli C; Pramstaller PP
Nephron Clin Pract; 2013; 123(1-2):102-11. PubMed ID: 23797027
[TBL] [Abstract][Full Text] [Related]
15. Short-term change in kidney function and risk of end-stage renal disease.
Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
[TBL] [Abstract][Full Text] [Related]
16. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
[TBL] [Abstract][Full Text] [Related]
17. Are eGFR equations better than IDMS-traceable serum creatinine in classifying chronic kidney disease?
Pottel H; Martens F
Scand J Clin Lab Invest; 2009; 69(5):550-61. PubMed ID: 19337946
[TBL] [Abstract][Full Text] [Related]
18. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
Corbett M; Duarte A; Llewellyn A; Altunkaya J; Harden M; Harris M; Walker S; Palmer S; Dias S; Soares M
Health Technol Assess; 2020 Aug; 24(39):1-248. PubMed ID: 32840478
[TBL] [Abstract][Full Text] [Related]
19. An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease.
Levy AR; Perkins RM; Johnston KM; Sullivan SD; Sood VC; Agnese W; Schnitzler MA
Int J Nephrol Renovasc Dis; 2014; 7():271-80. PubMed ID: 25061330
[TBL] [Abstract][Full Text] [Related]
20. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
